Nexome Genomics


Nexome Genomics provides cloud-based, integrated analytics solutions that empower healthcare institutions with on-demand access to precision medicine. Their technology leverages next-generation sequencing (NGS) data to improve disease diagnosis and personalize treatment strategies, supporting medical centers, hospitals, and physician offices in generating diagnostic and prognostic reports. Since 2016, based in Maryland, USA, Nexome focuses on developing advanced genomic data analytics and reporting systems to facilitate precise clinical reporting and support the growing field of personalized medicine.

Industries

biopharma
biotechnology
genetics

Nr. of Employees

small (1-50)

Nexome Genomics

604 S. Frederick Avenue, Gaithersburg, MD 20877, USA


Products

Cloud-hosted NGS data analytics and reporting platform

A platform for storage, processing, and clinical reporting of NGS datasets, providing automated analysis and report generation to institutional customers.

Targeted oncology gene panels (pan-cancer and tumor-specific)

A set of targeted NGS panels designed for oncology applications, covering pan-cancer and tumor-specific gene sets to detect mutations relevant to diagnosis and treatment.


Services

On-demand cloud service that processes NGS data to produce diagnostic and prognostic reports for healthcare institutions.

Expertise Areas

  • NGS data analysis and clinical reporting
  • Oncology genomics and targeted panel development
  • Bioinformatics and statistical genomics
  • Genomic data storage and cloud infrastructure
  • Show More (3)

Key Technologies

  • Next-generation sequencing (NGS)
  • Cloud-based analytics platforms
  • Targeted gene panels
  • Variant calling and indel analysis
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.